Navigation Links
FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
Date:5/2/2011

RIDGEFIELD, Conn. and INDIANAPOLIS, May 2, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved Tradjenta™ (linagliptin) tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. TRADJENTA can be used as monotherapy or in combination with other commonly prescribed medications for type 2 diabetes — metformin, sulfonylurea or pioglitazone — and demonstrated reductions in hemoglobin A1C (HbA1C or A1C) levels up to 0.7 percent (compared to placebo). A1C is measured in people with diabetes to provide an index of blood sugar control for the previous two to three months. TRADJENTA should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (increased ketones in the blood or urine). It has not been studied in combination with insulin.  

TRADJENTA belongs to a class of prescription medications called dipeptidyl peptidase-4 (DPP-4) inhibitors and is the first member of its class to be approved at one dosage strength (5 mg, once daily). With TRADJENTA, no dose adjustment is recommended for patients with kidney or liver impairment. TRADJENTA is a tablet that can be taken with or without food. TRADJENTA lowers blood sugar in a glucose-dependent manner by increasing incretin levels, which increase insulin levels after meals and throughout the day.  

"Many people with type 2 diabetes are not able to control their blood sugar with diet and exercise alone and may also require one or more medications," said John Gerich M.D., professor of medicine, University of Rochester School of Medicine. "The FDA approval of TRADJENTA is exciting because there is only one dose to remember for all patients, regardless of kidney or liver impairment. W
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... NEW YORK , May 22, 2015 /PRNewswire/ ... segment of the $13 billion global cardiac rhythm ... Kalorama Information.  Kalorama found that Medtronic, St. Jude ... Medical) command 80% of this market segment. The ... Management Device Markets , uses 2015 as a ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, ... announced a peer-reviewed publication of the results of ... RGN-259 (RegeneRx,s preservative-free eye drops) for the treatment ... adverse environment (CAE ® ) model.  The exploratory ... results, which were previously disseminated by the Company ...
(Date:5/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/3rthk2/latest ... "Latest Regulations on Pharmaceutical International Multi-Center Clinical Trials ... This is first time in history, Chinese ... multi-center clinical trials of drugs in ... implemented on March 1, 2015. The guidance provides ...
Breaking Medicine Technology:Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... Recovery Systems announced today that it has been awarded ... the group purchasing unit of the Premier healthcare alliance, ... its more than 75,000 healthcare member facilities. After hearing ... LRS Director of Marketing commented, " We are very ...
... "Simple Inspirations," a new contest, sponsored by Bayer ... diagnosed patients by sharing their most inspirational thoughts about ... is to enrich the lives of everyone who has ... -- and to demonstrate that people with diabetes can ...
Cached Medicine Technology:Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management 2Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management 3Nick Jonas and Bayer HealthCare Announce "Simple Inspirations" Contest to Motivate and Support Those Newly Diagnosed with Diabetes 2Nick Jonas and Bayer HealthCare Announce "Simple Inspirations" Contest to Motivate and Support Those Newly Diagnosed with Diabetes 3
(Date:5/23/2015)... May 23, 2015 With the implementation ... are finding it increasingly difficult to provide their employees ... to provide adequate insurance for employees stand to face ... such an integral part of a business’s success or ... for businesses, Online USA Doctors has created a varying ...
(Date:5/23/2015)... 23, 2015 On May 16, the team ... event was a 5k mud obstacle run that raised funds ... million people worldwide, and the reason we participated was to ... Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred percent of the ... , The event was not only attended by eXtreme Bodyshaping ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 A live auction ... equipment from hospitals, surgery centers and other medical facilities around ... sold including endoscopy, lab, radiology, surgery, anesthesia, exam and much ... May 27 and Thursday, May 28 starting at 9:00am CDT ... at 1400 N. 25th Avenue, Melrose Park, IL 60160. ...
(Date:5/23/2015)... May 23, 2015 Add High-Quality prismatic refractions ... Film Studios. , It's as simple as dragging and dropping ... included tool for full effect. , Including over 80 ... range 5k sensors making this the ultimate bundle for adding ... included in this package are movie files designed for Final ...
(Date:5/22/2015)... The world is at a "hinge ... to create new opportunities for leadership in health ... WesternU's 34th annual Commencement Exercises said Wednesday, May ... former San Francisco mayor and likely 2018 gubernatorial ... ceremony for WesternU's colleges of Allied Health Professions ...
Breaking Medicine News(10 mins):Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3
... Hopkins University School of Medicine have found that an ... in the embryonic development and the liver's own response ... cancer. ,The cell-signalling pathway called Hedgehog is ... could lead to the development of targeted treatment of ...
... take up organic farming according to the decision taken by ... hill town of Dharmasala.// ,'Under an integrated development ... fertilisers,' said a spokesman of the Tibetan government led by ... Tibetan refugees living in India and some of them have ...
... is all set to propagate a new method of sex ... Xiaoping, vice president with the China Family Planning Association, said: ... but sex education is lagging behind.' ,China now ... and about 20 million become sexually mature each year. ...
... to be cautious about monitoring blood sugar levels, which ... vessels that course through the lower limbs, giving rise ... risk for diabetics to suffer lower limb amputations is ... has reported. ,Wolverhampton-based researchers have reported that ...
... kids in Britain, increasing their susceptibility to diabetes. // ... to school as compared to 67% of the children in the ... sedentarily, watching television or playing at the computer. This is leading ... only in the above 40 age group. ,In Britain, more ...
... most important and natural activity we carry on in order ... and after with the Lungs. // Normally the lungs of ... the first cry activates this respiration surface. But the main ... well formed. Moreover, they often lack surfactant, which is a ...
Cached Medicine News:Health News:Unchecked Cellular Repair Pathway Causes Liver Cancer 2Health News:Liquid Respiration Respirator For Premature Babies 2
Slightly curved blunt dissector, double-ended. Length 11 1/2" (272 mm)...
Leroy-Raney scalp clips, sterile, disposable, plastic, ten clips/package....
Disposable scalp clip applier, comes loaded with 12 Leroy-Raney clips, ergonomic, easy to handle and position the clip....
... Multifunctional instrumentation, capable of ... tissue by means of ultra-sonic ... on organs, and, in particular, ... advantages of tissue-selection and non-traumatic ...
Medicine Products: